ISSN 1662-4009 (online)

ey0020.5-6 | Clinical Guidance and Studies | ESPEYB20

5.6. Neuroimaging in 205 consecutive children diagnosed with central precocious puberty in Denmark

AB Hansen , CH Renault , D Wojdemann , P Gideon , A Juul , RB Jensen

Brief summary: This Danish single-center retrospective study evaluated the occurrence of pathological findings on neuroimaging among children diagnosed with central precocious puberty (CPP).CPP incidence has been increasing over the last four decades (1) and is more prevalent in females than in males. Most cases are idiopathic (2) but brain magnetic resonance imaging (MRI) is routinely performed in order to exclude rare pathological causes.<p class="...

ey0021.7-1 | Clinical Guidance and Studies | ESPEYB21

7.1. Girls with idiopathic central precocious puberty did not display substantial changes in body mass index after treatment with gonadotropin-releasing hormone analogues

CS Uldbjerg , YH Lim , CH Renault , D Hansen , A Juul , EV Brauner , RB Jensen

Brief Summary: This retrospective study of 123 Danish girls treated with GnRHa for idiopathic central precocious puberty (CPP) shows that GnRH agonists do not impact body mass index during and after cessation of treatment.The use of GnRH agonists (GnRHa) for treatment of girls with CPP is well established but the potential long term effects of GnRHa remain a matter of debate, especially regarding their impact on weight evolution1,2.<p clas...